Short Sellers Stepping Back From 3D Printing Stocks

Short interest in the two-week period ending November 28 fell for three of the four 3D printing companies we follow.

Published December 10, 2014, 10:20am ET · 2 min read

3D printing

Thinkstock
Short interest in the two-week period ending November 28 fell for three of the four 3D printing companies we follow. Year to date, share prices are down more than 60% for all but one of these stocks. During this two-week reporting period, share prices rose for three of the four. 3D printing company stocks have taken a beating this year and short sellers may be taking a breather while shares remain near 52-week lows.

Short interest in 3D Systems Corp. (NYSE: DDD) fell 0.9% to 36.7 million shares. Some 34.8% of the company’s stock is short. Days to cover rose to 13. In the two-week short interest period to November 28, the share price rose 5.7% and is down about 65% for the year to date as of Tuesday night’s close. The stock’s 52-week range is $30.88 to $97.28, and shares closed at $32.13 Tuesday.

Stratasys Ltd. (NASDAQ: SSYS) saw short interest rise 8.4% in the final two weeks of November to 8.96 million shares, or about 20.4% of the company’s float. Days to cover increased to nine. Shares rose about 0.9% in the two-week period and closed at $88.31 Tuesday night. The stock’s price has dropped about 34% for the year to date. The stock’s 52-week range is $85.30 to $138.10.

Short interest in The ExOne Co. (NASDAQ: XONE) fell 10% to 3.88 million shares. About 42.8% of the company’s shares are now short. Shares of ExOne jumped nearly 18% in the two-week period and closed at $18.88 on Tuesday night, down about 69% year to date. The stock’s 52-week range is $16.00 to $70.25, and days to cover rose to 13.

Voxeljet A.G. (NYSE: VJET) saw short interest drop 6% to 2.66 million shares, with days to cover falling to seven. Year to date, shares are down about 69%, and they fell nearly 12% in the two-week period to November 28. The stock closed at $8.45 Tuesday, in a 52-week range of $8.12 to $47.98.

ALSO READ: Are Investors Signaling Optimism in Biotechs Through Short Interest?

Contact [email protected] for any questions or corrections.

Paul Ausick

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

All articles →